These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 24800505)
1. [Differential diagnosis of primary aldosteronism by measurement of hybrid steroids using mass spectrometry]. Wada N; Jin S; Hui SP; Yanagisawa K; Kurosawa T; Chiba H Rinsho Byori; 2014 Mar; 62(3):276-82. PubMed ID: 24800505 [TBL] [Abstract][Full Text] [Related]
2. Adrenal transitional zone steroids, 18-oxo and 18-hydroxycortisol, useful in the diagnosis of primary aldosteronism, are ACTH-dependent. Hamlet SM; Gordon RD; Gomez-Sanchez CE; Tunny TJ; Klemm SA Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):317-22. PubMed ID: 2856057 [TBL] [Abstract][Full Text] [Related]
3. Quantification of urinary 18-hydroxycortisol using LC-MS/MS. Jin S; Wada N; Takahashi Y; Hui SP; Sakurai T; Fuda H; Takeda S; Fujikawa M; Yanagisawa K; Ikegawa S; Kurosawa T; Chiba H Ann Clin Biochem; 2013 Sep; 50(Pt 5):450-6. PubMed ID: 23847032 [TBL] [Abstract][Full Text] [Related]
4. DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids? Lenders JWM; Williams TA; Reincke M; Gomez-Sanchez CE Eur J Endocrinol; 2018 Jan; 178(1):R1-R9. PubMed ID: 28904009 [TBL] [Abstract][Full Text] [Related]
5. An LC-MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism. Peitzsch M; Dekkers T; Haase M; Sweep FC; Quack I; Antoch G; Siegert G; Lenders JW; Deinum J; Willenberg HS; Eisenhofer G J Steroid Biochem Mol Biol; 2015 Jan; 145():75-84. PubMed ID: 25312486 [TBL] [Abstract][Full Text] [Related]
6. Optimizing adrenal vein sampling in primary aldosteronism subtyping through LC-MS/MS and secretion ratios of aldosterone, 18-oxocortisol, and 18-hydroxycortisol. Chang YL; Chen GY; Lee BC; Chen PT; Liu KL; Chang CC; Weng TI; Wu VC; Lin YH; Hypertens Res; 2023 Aug; 46(8):1983-1994. PubMed ID: 37311968 [TBL] [Abstract][Full Text] [Related]
9. 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. Mulatero P; di Cella SM; Monticone S; Schiavone D; Manzo M; Mengozzi G; Rabbia F; Terzolo M; Gomez-Sanchez EP; Gomez-Sanchez CE; Veglio F J Clin Endocrinol Metab; 2012 Mar; 97(3):881-9. PubMed ID: 22238407 [TBL] [Abstract][Full Text] [Related]
10. Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS. Fuss CT; Brohm K; Kurlbaum M; Hannemann A; Kendl S; Fassnacht M; Deutschbein T; Hahner S; Kroiss M Eur J Endocrinol; 2021 Jan; 184(1):167-178. PubMed ID: 33112272 [TBL] [Abstract][Full Text] [Related]
11. Primary aldosteronism: renaissance of a syndrome. Young WF Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946 [TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases]. Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213 [TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F; J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566 [TBL] [Abstract][Full Text] [Related]
14. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447 [TBL] [Abstract][Full Text] [Related]
15. Recent Developments in Primary Aldosteronism. Asbach E; Williams TA; Reincke M Exp Clin Endocrinol Diabetes; 2016 Jun; 124(6):335-41. PubMed ID: 27219889 [TBL] [Abstract][Full Text] [Related]
16. Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism. Eisenhofer G; Dekkers T; Peitzsch M; Dietz AS; Bidlingmaier M; Treitl M; Williams TA; Bornstein SR; Haase M; Rump LC; Willenberg HS; Beuschlein F; Deinum J; Lenders JW; Reincke M Clin Chem; 2016 Mar; 62(3):514-24. PubMed ID: 26787761 [TBL] [Abstract][Full Text] [Related]
18. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism. Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298 [TBL] [Abstract][Full Text] [Related]
19. Determination of three C18-oxygenated steroids in adrenal lesion segments in primary aldosteronism by super-selective adrenal venous sampling and LC/ESI-MS/MS. Mizumoto Y; Hirakawa A; Sugiura Y; Nishikawa T; Nishimoto K; Mano Y; Higashi T Biomed Chromatogr; 2024 May; 38(5):e5841. PubMed ID: 38324999 [TBL] [Abstract][Full Text] [Related]
20. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma. Rossi GP; Ragazzo F; Seccia TM; Maniero C; Barisa M; Calò LA; Frigo AC; Fassina A; Pessina AC Hypertension; 2012 Aug; 60(2):431-6. PubMed ID: 22733469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]